These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 20545523

  • 1. Development of dorzolamide hydrochloride in situ gel nanoemulsion for ocular delivery.
    Ammar HO, Salama HA, Ghorab M, Mahmoud AA.
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1330-9. PubMed ID: 20545523
    [Abstract] [Full Text] [Related]

  • 2. Development of loteprednol etabonate-loaded cationic nanoemulsified in-situ ophthalmic gel for sustained delivery and enhanced ocular bioavailability.
    Patel N, Nakrani H, Raval M, Sheth N.
    Drug Deliv; 2016 Nov; 23(9):3712-3723. PubMed ID: 27689408
    [Abstract] [Full Text] [Related]

  • 3. Cyclodextrin solubilization of carbonic anhydrase inhibitor drugs: formulation of dorzolamide eye drop microparticle suspension.
    Jansook P, Stefánsson E, Thorsteinsdóttir M, Sigurdsson BB, Kristjánsdóttir SS, Bas JF, Sigurdsson HH, Loftsson T.
    Eur J Pharm Biopharm; 2010 Oct; 76(2):208-14. PubMed ID: 20637867
    [Abstract] [Full Text] [Related]

  • 4. Design and evaluation of thermoreversible in situ gelling system of forskolin for the treatment of glaucoma.
    Gupta S, Samanta MK.
    Pharm Dev Technol; 2010 Oct; 15(4):386-93. PubMed ID: 19772380
    [Abstract] [Full Text] [Related]

  • 5. Topical drug delivery to the eye: dorzolamide.
    Loftsson T, Jansook P, Stefánsson E.
    Acta Ophthalmol; 2012 Nov; 90(7):603-8. PubMed ID: 22269010
    [Abstract] [Full Text] [Related]

  • 6. Preparation and evaluation of in situ gelling ophthalmic drug delivery system for methazolamide.
    Qian Y, Wang F, Li R, Zhang Q, Xu Q.
    Drug Dev Ind Pharm; 2010 Nov; 36(11):1340-7. PubMed ID: 20849349
    [Abstract] [Full Text] [Related]

  • 7. Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration.
    Sigurdsson HH, Stefánsson E, Gudmundsdóttir E, Eysteinsson T, Thorsteinsdóttir M, Loftsson T.
    J Control Release; 2005 Jan 20; 102(1):255-62. PubMed ID: 15653150
    [Abstract] [Full Text] [Related]

  • 8. Promising ion-sensitive in situ ocular nanoemulsion gels of terbinafine hydrochloride: design, in vitro characterization and in vivo estimation of the ocular irritation and drug pharmacokinetics in the aqueous humor of rabbits.
    Tayel SA, El-Nabarawi MA, Tadros MI, Abd-Elsalam WH.
    Int J Pharm; 2013 Feb 25; 443(1-2):293-305. PubMed ID: 23333217
    [Abstract] [Full Text] [Related]

  • 9. Designing of a pH-Triggered Carbopol®/HPMC In Situ Gel for Ocular Delivery of Dorzolamide HCl: In Vitro, In Vivo, and Ex Vivo Evaluation.
    Kouchak M, Mahmoodzadeh M, Farrahi F.
    AAPS PharmSciTech; 2019 Jun 03; 20(5):210. PubMed ID: 31161269
    [Abstract] [Full Text] [Related]

  • 10. Influence of various concentrations of terpene-4-ol enhancer and carbopol-934 mucoadhesive upon the in vitro ocular transport and the in vivo intraocular pressure lowering effects of dorzolamide ophthalmic formulations using albino rabbits.
    Afouna MI, Khedr A, Abdel-Naim AB, Al-Marzoqi A.
    J Pharm Sci; 2010 Jan 03; 99(1):119-27. PubMed ID: 19530071
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Sustained ocular delivery of Dorzolamide-HCl via proniosomal gel formulation: in-vitro characterization, statistical optimization, and in-vivo pharmacodynamic evaluation in rabbits.
    Fouda NH, Abdelrehim RT, Hegazy DA, Habib BA.
    Drug Deliv; 2018 Nov 03; 25(1):1340-1349. PubMed ID: 29869516
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Ocular poloxamer-based ciprofloxacin hydrochloride in situ forming gels.
    Mansour M, Mansour S, Mortada ND, Abd Elhady SS.
    Drug Dev Ind Pharm; 2008 Jul 03; 34(7):744-52. PubMed ID: 18612913
    [Abstract] [Full Text] [Related]

  • 17. Chitosan in situ gelation for improved drug loading and retention in poloxamer 407 gels.
    Ur-Rehman T, Tavelin S, Gröbner G.
    Int J Pharm; 2011 May 16; 409(1-2):19-29. PubMed ID: 21335076
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ion- and pH-activated novel in-situ gel system for sustained ocular drug delivery.
    Gupta H, Velpandian T, Jain S.
    J Drug Target; 2010 Aug 16; 18(7):499-505. PubMed ID: 20055752
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.